Nektar (NKTR) reports agreement to sell Cimzia(R) and Mircera(R) royalties to Royalty Pharma for $124M
Tweet Send to a Friend
Up)
Nektar (Nasdaq: NKTR) reports agreement to sell Cimzia(R) and Mircera(R) royalties to Royalty Pharma for $124M
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Correct: Buying Warner Chilcott plc (WCRX) Seen as Takeover Defense by Actavis (ACT)
- Novartis (NVS) has no intention of pursing a bid for Actavis, Inc. (ACT)
- Quest (DGX) Acquires Concentra Assets; Enters Long-Term Agreement
Create E-mail Alert Related Categories
Mergers and Acquisitions, Trading Halts
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
